Trials / Completed
CompletedNCT01995136
Investigation of Intraocular Pressure (IOP) Reduction Efficacy of Travoprost Ophthalmic Solution in Patients With Normal Tension Glaucoma
Investigation of the Effect of Travoprost Ophthalmic Solution of Lowering Intraocular Pressure in Patients With Normal Tension Glaucoma
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 32 (actual)
- Sponsor
- Alcon Research · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to investigate IOP reduction efficacy of travoprost 0.004% ophthalmic solution (TRAVATAN Z®) in subjects with normal tension glaucoma.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Travoprost Ophthalmic Solution 0.004% | benzalkonium chloride (BAC) free |
Timeline
- Start date
- 2013-09-01
- Primary completion
- 2014-06-01
- Completion
- 2014-06-01
- First posted
- 2013-11-26
- Last updated
- 2015-10-07
- Results posted
- 2015-07-20
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT01995136. Inclusion in this directory is not an endorsement.